[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 65, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 828750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 600000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2996, "open": 0.298, "dayLow": 0.2742, "dayHigh": 0.3201, "regularMarketPreviousClose": 0.2996, "regularMarketOpen": 0.298, "regularMarketDayLow": 0.2742, "regularMarketDayHigh": 0.3201, "payoutRatio": 0.0, "forwardPE": -0.11151944, "volume": 1288279, "regularMarketVolume": 1288279, "averageVolume": 2118370, "averageVolume10days": 1983150, "averageDailyVolume10Day": 1983150, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 14542817, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 4.17, "fiftyDayAverage": 0.2882, "twoHundredDayAverage": 1.6088, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6348994, "profitMargins": 0.0, "floatShares": 45326469, "sharesOutstanding": 46079900, "sharesShort": 1967439, "sharesShortPriorMonth": 2355367, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0427, "heldPercentInsiders": 0.01644, "heldPercentInstitutions": 0.109969996, "shortRatio": 1.72, "shortPercentOfFloat": 0.047, "impliedSharesOutstanding": 46079900, "bookValue": 0.299, "priceToBook": 1.0555184, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -44581448, "trailingEps": -1.41, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": 0.123, "52WeekChange": -0.9044776, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 0.3156, "targetHighPrice": 13.0, "targetLowPrice": 1.0, "targetMeanPrice": 5.66667, "targetMedianPrice": 3.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 23288608, "totalCashPerShare": 0.505, "ebitda": -51486044, "totalDebt": 494003, "quickRatio": 2.481, "currentRatio": 2.583, "debtToEquity": 3.151, "returnOnAssets": -1.72364, "returnOnEquity": -46.93382, "freeCashflow": -48243248, "operatingCashflow": -47583000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CLRB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1131633000000, "fiftyTwoWeekRange": "0.22 - 4.17", "postMarketChangePercent": -1.80609, "postMarketPrice": 0.3099, "postMarketChange": -0.00570002, "regularMarketChange": 0.016000003, "regularMarketDayRange": "0.2742 - 0.3201", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2118370, "fiftyTwoWeekLowChange": 0.09560001, "fiftyTwoWeekLowChangePercent": 0.4345455, "fiftyTwoWeekHighChange": -3.8544002, "fiftyTwoWeekHighChangePercent": -0.9243166, "fiftyTwoWeekChangePercent": -90.44776, "dividendDate": 1531785600, "earningsTimestamp": 1741863900, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1741869000, "earningsCallTimestampEnd": 1741869000, "isEarningsDateEstimate": true, "regularMarketChangePercent": 5.3404546, "regularMarketPrice": 0.3156, "corporateActions": [], "postMarketTime": 1741994069, "regularMarketTime": 1741982400, "exchange": "NCM", "messageBoardId": "finmb_37613299", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -1.41, "epsForward": -2.83, "epsCurrentYear": -0.64, "priceEpsCurrentYear": -0.49312502, "fiftyDayAverageChange": 0.027400017, "fiftyDayAverageChangePercent": 0.095072925, "twoHundredDayAverageChange": -1.2932, "twoHundredDayAverageChangePercent": -0.8038289, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "marketState": "CLOSED", "displayName": "Cellectar Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]